Greenville Health System Cancer Institute-Andrews — Greenville, South Carolina

Greenville Health System Cancer Institute-Andrews is a clinical research site located in Greenville, South Carolina, United States 29601.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Greenville Health System Cancer Institute-Andrews has participated in 91 clinical trials with 32 currently active.

Therapeutic areas: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Plasma Cell Myeloma.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, GOG Foundation.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Greenville Health System Cancer Institute-Andrews?

Greenville Health System Cancer Institute-Andrews has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Greenville Health System Cancer Institute-Andrews conducted?

Greenville Health System Cancer Institute-Andrews has 91 clinical trials on record, with 32 currently active. Their work covers Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Plasma Cell Myeloma.

Is Greenville Health System Cancer Institute-Andrews accredited by Crixeo Health?

Greenville Health System Cancer Institute-Andrews has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Greenville Health System Cancer Institute-Andrews?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.